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doi:10.1016/j.kjms.2011.11.004Abstract Ammonium acid urate (AAU) urolithiasis is a rare condition; however, it is endemic
in some countries, with an especially high incidence in Asia. This study was conducted to inves-
tigate the special presentation of patients with AAU urolithiasis in Taiwan. Reports of 3457
stones were retrospectively reviewed from January 2005 to January 2010 and 25 patients with
urinary stones (0.7%) containing AAU crystals were identified. The clinical and biochemical
presentation of all stones were compared to evaluate the specific comorbidities of AAU stones.
AAU stones were observed in 11 males (44%) and 14 females (56%) with a mean age of
60.60  16.81 years and mean body mass index of 25.55  3.73 kg/m2. AAU stones were
frequently observed in the bladder (44%) and they were significantly larger (mean size
1.90 cm) than the non-AAU stones (mean size 1.22 cm). Other significant comorbidities of
AAU stones included chronic kidney disease (CKD) (60%), urinary tract infections (UTIs)
(52%), irritable bowel syndrome (IBS) (36%), and gout (28%). In addition, there were also three
patients with coexisting urothelial carcinoma (12%) in the AAU-stone group. Patients with AAU
urolithiasis were predominantly female, older in age, had increased bladder presentation,
larger stones and a high percentage of coexisting CKD, UTIs, IBS, gout, and even urothelial
carcinoma. Therefore, it is important for clinicians to evaluate and protect renal function in
patients with AAU urolithiasis.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.t of Urology, Kaohsiung Medical University Hospital, Number 100, Tzyou 1st Road, Kaohsiung 807,
tw (C.-C. Tsai).
vier Taiwan LLC. All rights reserved.
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Urolithiasis is a disorder that is increasing in prevalence in
the tropics as well as in most Western countries [1]. The
lifetime prevalence of symptomatic urolithiasis is 5% to 10%
worldwide, with a male predominance; however, the inci-
dence of urolithiasis is increasing. Unlike common calcium-
containing stones, ammonium acid urate (AAU) urolithiasis
is quite rare in patients with urinary stones (< 1%) [1];
however, AAU urolithiasis is still observed in developing
countries, especially in Asia [2]. Urolithiasis generally arises
from disturbances of the physiochemical balance and the
hydrodynamic system in the urinary tract. Some studies
have reported special risk factors for AAU urolithiasis,
including irritable bowel syndrome (IBS), laxative abuse,
obesity, urinary diversion, pregnancy, chemotherapy, and
recurrent urinary tract infections (UTIs) [3e5]; however,
idiopathic AAU crystals may also develop in the absence of
these risk factors. The actual etiology and pathophysiology
of stones containing AAU crystals are still not completely
understood. Hence, the present study aimed to investigate
the clinical and biochemical presentation of AAU urolith-
iasis in Taiwan.
Methods
This study was approved by our hospital’s institutional
review board. From January 2005 to January 2010, 3457
patients were diagnosed with urolithasis and underwent
stone analysis at Kaohsiung Medical University Hospital and
Kaohsiung Municipal Hsiao-Kang Hospital. They were strat-
ified into two groups according to whether or not their
stones contained AAU crystals. The hospital charts of all
patients were reviewed for socio-demographic character-
istics, detailed physical examination results, body mass
index (BMI), and medical history. Biochemical analysis of
blood samples, including creatinine, calcium, uric acid, and
urine pH (the first morning urine sample), was also
collected. The glomerular filtration rate (GFR) was calcu-
lated with the Cockcroft-Gault equation. Stone presenta-
tion was evaluated in terms of their size, site, and number,
using a kidneyeureterebladder film or ultrasonography to
obtain a definitive diagnosis. The composition of all stones
was analyzed by infrared spectrophotometry (Spectrum RX I
Fourier Transform-Infrared System, Perkin Elmer, USA).
Potential comorbid risks that may be associated with AAU
stone formation were recorded by chart review and tele-
phone interviews. Obesity was defined as a BMI of >27 kg/
m2. Gout was defined as a history of hyperuricemia and
clinical arthropathy. Laxative abuse was defined as taking
laxatives without a prescription [6]. IBS was defined on the
basis of the Rome III criteria [7]. Patients with renal failure,
renal tubular acidosis, hyperparathyroidism, or osteopo-
rosis and those using medications such as diuretics, vitamin
D or calcium supplements were excluded from the study.
The demographic and clinicopathologic characteristics of
the patients in the two groups were compared using Pear-
son’s Chi-square test or Student t test. Statistical analyses
were performed using JMP v8.0 statistical software. For all
statistical analyses, p < 0.05 was considered statistically
significant.Results
As AAU stones are difficult to differentiate from other
stones through gross examination, we analyzed stone
composition with infrared spectrophotometry (Fig. 1).
Among the 3457 patients with urolithiasis, 28 calculi from
25 patients (0.7%) contained AAU crystals. These patients
consisted of 11 males (44%) and 14 females (56%) with
a mean age of 60.60  16.81 years and a mean BMI of
25.55  3.73 kg/m2. The mean serum creatinine and GFR
levels were 1.24  0.45 mg/dL and 59.57  26.56 mL/min,
respectively. The clinical characteristics and laboratory
data of the patients with stones, categorized by the pres-
ence or absence of an AAU crystal, are shown in Table 1.
The patients with AAU stones were significantly more likely
to be female (p Z 0.002), of older age (p Z 0.008), and
have a lower mean GFR (p Z 0.002) than those with non-
AAU stones. However, the BMI, family history of urolith-
iasis, urine pH, serum uric acid, and serum calcium levels of
the two groups were similar. Although 429 cases in the non-
AAU-stone group had inadequate stone presentation data
because of radiolucent stones, the patients with AAU stones
still had a significantly higher proportion of bladder stones
(44% vs. 24%, respectively, p Z 0.021) and larger mean
stone size (1.90 cm vs. 1.22 cm, respectively, p Z 0.007)
than those with non-AAU stones. A UTI with a positive
culture was noted in more than half of the patients (52%) in
the AAU group and most of them had Proteus, Klebsiella, or
Escherichia coli infections. Of those patients with AAU
stones, 15 (60%) were diagnosed with chronic kidney
disease (CKD), which was defined as a GFR of <60 mL/min.
The AAU-stone group had a significantly higher proportion
of patients with CKD (pZ 0.001), UTI with positive culture
(pZ 0.002), IBS (pZ 0.001), and gout (pZ 0.027) than the
non-AAU-stone group; however, there was no significant
difference in laxative abuse between the two groups.
Although the number of patients analyzed was small, there
was a trend toward a higher incidence of urothelial carci-
noma in the AAU-stone group than in the non-AAU-stone
group (12% vs. 1.7%, respectively, p Z 0.009). Another
interesting finding was the pH of the urine. We compared
the pH of the urine from the patients with AAU, uric acid
(243 cases), and struvite (magnesium ammonium phos-
phate; 25 cases) stones. The mean urine pH of the patients
with AAU, uric acid, and struvite stones was 6.36  0.47,
5.33  0.30, and 7.22  0.52, respectively, with a statisti-
cally significant difference between the groups
(p < 0.0001). The urine pH level of those with AAU stones
was higher than that of the patients with uric acid stones
and lower than that of those with struvite stones (Fig. 2).
Discussion
Urolithiasis with AAU crystals can be classified as endemic
or sporadic. Endemic cases are still observed in developing
countries, and AAU urolithiasis was frequently seen at the
beginning of the 20th century, particularly bladder calculi
in children [8]. Nutritionally poor diets that are low in
animal protein, calcium, and phosphate, but high in cereal,
greatly contribute to relatively high levels of ammonium
and urate ions, resulting in stone formation. Chronic
Figure 1. Stone compositions analyzed by infrared spectrophotometry. The AAU stone leads to an increase in the intensities of
the bands at 617,707, 1005, 1386, 1429 and 1655, compared with increases in intensity for the calcium stone at 517, 780, 1316 and
1623. AAU Z ammonium acid urate.
Ammonium acid urate urolithiasis 261diarrhea, which has a high incidence in developing coun-
tries, also leads to a loss of water and ions, which is another
major underlying factor for AAU crystallization [9]. In 1966,
Hsu et al. [10] noted that 38 out of 45 children with
urolithiasis in Taiwan had predominantly AAU stones.
However, the incidence of AAU stones has been decreasing
in most of the countries in the so-called “endemic bladder
stone belt” with gradual improvements in nutrition levels
and public health education. At present, sporadic cases of
AAU urolithiasis are unusual in industrialized countries, and
the prevalence varies with different geographical areas;
e.g., 0.3% in the United States [5], 0.38% in Japan [11], 0.7%in our study, and up to 0.75% in Norway [12]. In contrast,
there are still abnormally high incidences of AAU stones in
specific regions. Vincent et al. reported that the preva-
lence of AAU-containing stones was as high as 3.l% in North
America [4]. The apparent geographic variations indicate
that genetic, dietary, and environmental factors may play
important roles in the formation of AAU stones.
Due to the rare occurrence of AAU stones, only a few
studies have reported their clinical and biochemical
presentation, and the actual mechanism of AAU crystal
formation has not been well established. According to
previous pathophysiological evidence of urolithiasis
Table 1 Clinical characteristics and laboratory data of
the study population.
AAU
stones
Non-AAU
stones
p
Number 25 3432 0.002
Sex
Male, n (%) 11 (44) 2537 (74)
Female, n (%) 14 (56) 895 (26)
Age (y) 60.60  16.81 53.17  13.87 0.008
BMI (kg/m2) 25.55  3.73 25.59  3.89 0.955
Familial history, n (%) 7 (28) 927 (27) 0.991
Stone presentationa
Single, n (%) 11 (44) 1719 (50) 0.544
Size (cm) 1.90  1.31 1.22  1.18 0.007
Bladder stone, n (%) 11 (44) 828 (24) 0.021
Laboratory data
Serum uric acid
(mg/dL)
7.00  1.78 7.18  2.01 0.645
Serum calcium
(mg/dL)
8.88  0.60 8.76  0.58 0.301
Urinary pH 6.36  0.47 6.26  0.63 0.427
CG-GFR (mL/min) 59.57  26.56 78.64  29.69 0.002
Comorbidities
Chronic kidney
disease, n (%)
15 (60%) 892 (26%) 0.001
UTI with positive
culture, n (%)
13 (52%) 831 (24%) 0.002
Proteus 4
Klebsiella 3
Escherichia coli 3
Pseudomonas 2
Staphylococcus 1
Others 2
IBS, n (%) 9 (36) 446 (13) 0.001
Laxative abuse, n (%) 7 (28) 1132 (33) 0.597
Gout, n (%) 7 (28) 447 (13) 0.027
Urothelium
carcinoma, n (%)
3 (12) 57 (1.7) 0.009
a A total of 429 cases had inadequate data due to radiolucent
stones on X-ray.
AAU Z ammonium acid urate; CG-GFR Z Cockcroft-Gault
glomerular filtration rate; IBS Z irritable bowel syndrome;
UTI Z urinary tract infection.
Figure 2. Correlation between urine pH and stone compo-
nent. Vertical bars indicate mean  SD. AAUZ ammonium acid
urate.
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formation have been discussed, including gastrointestinal
loss of water and ions, volume depletion with
supersaturation-related crystallization, decreased inhibi-
tors of stone formation, and increased levels of urinary
urate and ammonium [3e5]. Although these mechanisms
are believed to involve multiple factors, a growing number
of studies have identified the key roles of increased levels
of urinary ammonium and urate in the development of AAU
urolithiasis. Under physiological conditions, urinary
ammonia levels are maintained at approximately 100 mEq/
L. Urease can hydrolyze urea to ammonia and CO2, andbacterial urease, which is normally intracellular, is released
into the urine after the lysis of bacterial cells [14]. As
a result, a UTI with urease-producing bacteria could
increase the levels of urinary ammonium and lead to highly
alkaline urine, both being preconditions for the formation
of struvite and AAU crystals. In our study, more than half of
the patients with AAU stones had a UTI, which was signifi-
cantly higher than in the patients with non-AAU stones.
Most of the detected pathogens were common urease-
producing pathogens, such as Proteus, Klebsiella, Pseudo-
monas, and Staphylococcus [14]. By contrast, a previous
study indicated that patients with AAU and uric acid stones
overproduce and overexcrete uric acid [15]. Hyperuricemia
and a purine-rich and phosphorus-poor diet combined with
low fluid intake would not only give rise to gout attacks, but
also promote the formation of highly concentrated uric
acid, which forms ions and salts that are known as urates
and acid urates, in urine. When excessive levels of ammo-
nium combine with enough acid urates in urine, AAU crys-
tals are produced. In this study, we observed significant
associations between AAU stone formation and both UTIs
and gout (p Z 0.002 and 0.027, respectively).
Another important factor of AAU crystallization involves
the solubility and stability of supersaturated ammonium
and acid urate, which are strongly affected by the urinary
pH level. Previous studies have demonstrated associations
between urinary pH and various stones. The normal renal
handling of urate is a complicated process resulting in
a fractional clearance of 8.2% to 10.3%. Uric acid ionizes to
form urate at pH 5.75, and uric acid solubility is strongly
increased by urinary pH [16]. Conversely, a lower urinary
pH level increases the concentration of the sparingly
soluble undissociated uric acid, which directly promotes
the formation of uric acid stones [17]. Struvite stone
formation is highly correlated with urease-producing uro-
pathogens and highly alkaline urine. Struvite only precipi-
tates at a pH value of higher than 7.2. When urine is
acidified, struvite can no longer precipitate and begins to
dissolve [14]. Bowyer et al. [18] found that AAU crystals
disappeared from urine with a pH value of <5.7 and that
Ammonium acid urate urolithiasis 263the minimum concentration of AAU crystals formed at pH
values of between 6.2 and 6.3. Therefore, the urinary pH
favoring AAU stone formation would be between that of
struvite stones and uric acid stones, possibly because the
urine of patients with AAU stones is supersaturated with
ammonium and urate. This is consistent with our findings
that showed the AAU-stone group had a similar mean urine
pH level (pH Z 6.36  0.47). The patients with struvite
stones had the highest mean urinary pH, while those with
uric acid stones had the lowest level (Fig. 2).
Traditionally, AAU stones were considered to correlate
with frequent diarrhea, laxative abuse, IBS, and anorexia
nervosa [3,4,19,20]. Possible causes include a volume-
depleted state and intracellular metabolic acidosis caused
by the loss of water and electrolytes. A 24-hour urine study
showed a marked decrease in volume, and sodium, citrate,
and potassium levels in people abusing laxatives [21]. The
aforementioned conditions is the volume depleted state
and intracellular metabolic acidosis. Soble et al. [5]
reported that a history of inflammatory bowel disease or
diverting ileostomy is a risk factor for AAU urolithiasis, and
the plausible mechanism is similar to that for laxative
abuse. In our study, IBS was significantly associated with
AAU stone formation in univariate analysis (pZ 0.001), but
laxative abuse was not (p Z 0.597). These results differ
from those of other reports. We believe that insufficient
numbers of patients and inadequate data collection during
telephone interviews are two major factors contributing to
these differences. The multiplicity of characteristics in our
AAU patients also demonstrates that AAU crystal formation
is the result of multiple factors.
However, we did observe some trends in the features of
the patients in the AAU-stone group compared with those in
the non-AAU-stone group. For example, AAU stones tended
to be larger and had a higher incidence of forming in the
bladder. There were also significantly more females and
patients of an older age in the AAU-stone group than in the
non-AAU-stone group. A plausible reason for these obser-
vations may lie in the relatively high prevalence of UTIs and
asymptomatic bacteriuria in this group of patients. The
prevalence of asymptomatic bacteriuria among healthy,
community-residing women increases with advancing age,
from about 1% among school girls to >20% among women
aged >80 years [22]. Certain common physiological changes
may also increase the likelihood of AAU stone formation.
Loss of nephron mass is an important and predictable
feature of aging that reduces the GFR by approximately
1 mL/min for every year over 40 years of age, and alter-
ations in kidney function are more significant in aging
females. In our study, there was also a significant reduction
of GFR in the AAU-stone group compared with the non-AAU-
stone group (59.57 vs. 78.64 mL/min, respectively,
pZ 0.002). Furthermore, 60% of patients in the AAU-stone
group were affected by CKD with a Cockcroft-Gault-
estimated GFR of <60 mL/min. Despite the fact that
accumulating evidence has identified an association
between urolithiasis and CKD [23], the precise etiology of
this relationship has not been well established. Further
studies are needed to evaluate the factors that underlie
this association; e.g., whether alterations in ion and water
excretion could contribute to the instability of AAU super-
saturation or whether poor nutritional status couldcontribute to the high levels of ammonium and urate ions in
urine.
Another particularly noteworthy finding in this study is
the coexistence of AAU crystals and urothelial carcinoma.
Urolithiasis has been considered to be a risk factor for
urothelial carcinoma [24]. Although the exact mechanism
has not been proven, it is thought to involve chronic
inflammation and mucosal irritation that leads to urothelial
proliferation and eventual malignant transformation.
Notwithstanding the small number of patients studied, we
found an abnormally high coexistence (12%) of AAU stones
and urothelial carcinoma. This made us wonder whether
components of AAU crystals caused urothelial carcinoma or
if the cytokines involved in urothelial carcinoma caused
AAU crystals. To elucidate the potential relationships
between these two conditions, further large-scale patho-
physiological studies are clearly needed.
There were some limitations in our study. Firstly, we did
not perform many of the available biochemical analyses of
urine, e.g., calcium and uric acid level determination. The
clinical presentation seemed to be inadequate for the
accurate estimation of the risk factors of AAU stones.
Secondly, AAU stones were not classified into pure and
mixed types. The pathophysiological mechanisms of AAU
urolithiasis may differ between the pure and mixed AAU
types. Hidetoshi et al. [11] reported that 70.0% of patients
with pure AAU stones engaged in laxative abuse compared
with 26.3% of patients with mixed stones. Incomplete
biochemical urine tests and inadequate classification data
might lead to inaccurate risk stratification. The final limi-
tations were that this study was retrospective and the
number of AAU patients analyzed was small. In addition,
variability in data collection during telephone interviews
was also inevitable. To investigate the actual underlying
correlation between the clinical characteristics and AAU
stones, 24-hour urine samples and fasting blood samples are
needed in further large-scale and well-distinguished
prospective studies.
Summary
In conclusion, the clinical and biochemical presentation of
patients with AAU urolithiasis included a female predomi-
nance, older age, more bladder presentations, larger size
of stones, and a higher percentage of coexisting CKD, UTIs,
IBS, gout, and urothelial carcinoma. A high proportion of
patients with renal insufficiency were diagnosed in this
study; therefore, in patients with AAU urolithiasis, it is
important for clinicians to not only evaluate comorbid
conditions but also to consider possible CKD and protect
renal function, especially in females and those of relatively
older ages.References
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